Physician profile
Amit Garg
NPI 1659371011
$10,719.06
in general payments reported to CMS, 2019-2025
38 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,638 · 2020: $303 · 2021: $408 · 2022: $313 · 2023: $640 · 2024: $144 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.24 |
| Education | $151.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $9,021.43 | 2019-2023 | |
| Astellas Pharma US INC | $217.35 | 2023-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $164.50 | 2019-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Aptima |
| Therapeuticsmd, INC. | $138.61 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $121.67 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.02 | 2019-2025 | |
| Coopersurgical, INC. | $92.83 | 2019-2025 | Onetrac Lx, Ally II Ups |
| Exeltis, USA INC. | $77.97 | 2020-2021 | |
| Medtronic, INC. | $55.67 | 2021-2023 | Truclear |
| Merck Sharp & Dohme LLC | $52.62 | 2020-2024 | Gardasil 9, Gardasil |
| Viiv Healthcare Company | $50.14 | 2023 | Apretude |
| Millicent US INC | $43.76 | 2025 | Femlyv |
| Baxter Healthcare | $39.91 | 2020 | |
| Pfizer INC. | $34.73 | 2019-2023 | |
| Daiichi Sankyo INC. | $34.21 | 2021-2024 | Injectafer |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $32.28 | 2021 | |
| Avion Pharmaceuticals | $32.27 | 2020-2023 | Balcoltra |
| Allergan, INC. | $31.81 | 2019 | |
| Sumitomo Pharma America, INC. | $30.95 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $30.72 | 2023-2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $26.71 | 2019 | |
| Novo Nordisk INC | $24.84 | 2022 | |
| Axonics, INC. | $19.92 | 2023 | Axonics, Bulkamid |
| Sobi, INC | $19.19 | 2024 | |
| Gynesonics, INC. | $18.92 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $18.47 | 2019 | |
| Agile Therapeutics, INC. | $17.56 | 2022 | |
| Minerva Surgical, INC | $16.23 | 2023 | |
| Sage Therapeutics, LLC | $16.12 | 2025 | Zurzuvae |
| Uroviu Corporation | $15.93 | 2022 | |
| Covidien LP | $15.37 | 2020 | |
| Dysis Medical, INC. | $14.94 | 2021 | |
| Solventum Corporation | $14.84 | 2025 | Prevena |
| Olympus America INC. | $14.32 | 2023 | Olympus |
| Medicem INC. | $13.96 | 2020 | |
| Lupin INC. | $13.41 | 2019 | |
| Pharmacosmos Therapeutics INC. | $13.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.85 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.